Table 1.
Clinical status of samples |
ATB, HIV +ve (n=139) |
ATB, HIV −ve (n=47) |
LTBI (n=83) |
NTB (n=10) |
rTMKmt + Control (n=2) |
|
---|---|---|---|---|---|---|
Function (ϝ) |
PAb-0655 (UG-Peptide 1 Derivative) Based Direct TMKmt Ag Detection |
|||||
Best fit values | ||||||
Y Intercept | 0.8081 ± 0.0329 | 0.2557 ± 0.0182 | 0.4577 ± 0.0129 | 0.2121 ± 0.0213 | 0.1660 ± 0.0112 | |
Slope | −0.0017 ± 0.0004 | 0.0006 ± 0.0006 | −0.0026 ± 0.0003 | 0.0019 ± 0.0034 | 0.9910 ± 0.0071 | |
Statistical significance | ||||||
P value | <0.0001 | 0.3513 | <0.0001 | 0.5912 | <0.0001 | |
Deviation from 0 | Significant | Not Significant | Significant | Not Significant | Significant | |
95% Confidence Interval | ||||||
Y Intercept | 0.7446 to 0.8715 | 0.2195 to 0.2918 | 0.4325 to 0.4829 | 0.1675 to 0.2567 | 0.1179 to 0.2141 | |
Slope | −0.0025 to −0.0010 | −0.0007 to 0.0019 | −0.0031 to −0.0020 | −0.0053 to 0.0091 | 0.9606 to 1.021 | |
Goodness of fit | ||||||
DFd | 1.000, 276.0 | 1.000, 92.00 | 1.000, 164.0 | 1.000, 18.00 | 1.000, 2.000 | |
R Square | 0.0635 | 0.0095 | 0.3619 | 0.0163 | 0.9999 | |
(n)x2 | 278 | 94 | 166 | 20 | 4 | |
Sy.x | 0.2686 | 0.0867 | 0.0821 | 0.044 | 0.0071 |